Imatinib mesylate in the treatment of chronic myeloid leukaemia

By Druker Brian J  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 6, 2003-06 ,pp. : 963-971

Informa Healthcare

Access to resources Recommend Favorite

Dasatinib Treatment for Imatinib Resistant or Intolerant Patients with Chronic Myeloid Leukaemia

By Li J   Xu G   Yu S   He L   Guo L  

The Journal of International Medical Research, Vol. 39, Iss. 2, 2011-03 ,pp. : 337-347

Field House Publishing

Access to resources Recommend Favorite

Imatinib: A Review of its Use in Chronic Myeloid Leukaemia

By Moen Marit D.   McKeage Kate   Plosker Greg L.   Siddiqui M. Asif A.  

Drugs, Vol. 67, Iss. 2, 2007-01 ,pp. : 299-320

Adis International

Access to resources Recommend Favorite

BMS-354825: a novel drug with potential for the treatment of imatinib-resistant chronic myeloid leukaemia

By Doggrell Sheila A  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 1, 2005-01 ,pp. : 89-91

Informa Healthcare

Access to resources Recommend Favorite

Cost Effectiveness of Imatinib Compared with Interferon- or Hydroxycarbamide for First-Line Treatment of Chronic Myeloid Leukaemia

By Dalziel Kim   Round Ali   Garside Ruth   Stein Ken  

PharmacoEconomics, Vol. 23, Iss. 5, 2005-01 ,pp. : 515-526

Adis International

Access to resources Recommend Favorite